"Kari Appachu, MD Basel Channis, MD Vikas Kalra, MD Divya Malladi, MD Pradeep Mehra, MD Clyde Mendonca, MD Stephen Schinker, MD Theodore Tzeremas, MD"

During the past decade, Southwest Kidney Institute conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Southwest Kidney Institute" #1 collaborator was "Harvard University" with 1 trials as a collaborator and "Massachusetts General Hospital" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Southwest Kidney Institute" are "Anemia of Chronic Kidney Disease" (1 trials), "Chronic Kidney Disease (CKD) Stage 5" (1 trials), "Chronic Kidney Failure" (1 trials) and "Hypertrophy, Left Ventricular" (1 trials). Many other conditions were trialed in "Southwest Kidney Institute" in a lesser frequency.

Most popular intervention types in "Southwest Kidney Institute" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Lanthanum carbonate" (1 trials), "Magnesium iron hydroxycarbonate" (1 trials), "Placebo Injection 4 mcg/mL" (1 trials) and "ferric citrate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Southwest Kidney Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Southwest Kidney Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Southwest Kidney Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Southwest Kidney Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".